BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15166288)

  • 1. Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.
    Sijwali PS; Kato K; Seydel KB; Gut J; Lehman J; Klemba M; Goldberg DE; Miller LH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8721-6. PubMed ID: 15166288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.
    Sijwali PS; Koo J; Singh N; Rosenthal PJ
    Mol Biochem Parasitol; 2006 Nov; 150(1):96-106. PubMed ID: 16890302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.
    Pandey KC; Singh N; Arastu-Kapur S; Bogyo M; Rosenthal PJ
    PLoS Pathog; 2006 Nov; 2(11):e117. PubMed ID: 17083274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.
    Sijwali PS; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4384-9. PubMed ID: 15070727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum.
    Dahl EL; Rosenthal PJ
    Mol Biochem Parasitol; 2005 Feb; 139(2):205-12. PubMed ID: 15664655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth.
    Eksi S; Czesny B; Greenbaum DC; Bogyo M; Williamson KC
    Mol Microbiol; 2004 Jul; 53(1):243-50. PubMed ID: 15225318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipain cysteine proteases of malaria parasites: An update.
    Rosenthal PJ
    Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2'.
    Singh N; Sijwali PS; Pandey KC; Rosenthal PJ
    Exp Parasitol; 2006 Mar; 112(3):187-92. PubMed ID: 16337629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.
    Sijwali PS; Shenai BR; Gut J; Singh A; Rosenthal PJ
    Biochem J; 2001 Dec; 360(Pt 2):481-9. PubMed ID: 11716777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites.
    Hopp CS; Bennett BL; Mishra S; Lehmann C; Hanson KK; Lin JW; Rousseau K; Carvalho FA; van der Linden WA; Santos NC; Bogyo M; Khan SM; Heussler V; Sinnis P
    PLoS Pathog; 2017 Sep; 13(9):e1006586. PubMed ID: 28922424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression.
    Dasaradhi PV; Mohmmed A; Kumar A; Hossain MJ; Bhatnagar RK; Chauhan VS; Malhotra P
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1062-8. PubMed ID: 16165088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
    Singh A; Rosenthal PJ
    J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.
    Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1064-70. PubMed ID: 17178799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum.
    Dasaradhi PV; Korde R; Thompson JK; Tanwar C; Nag TC; Chauhan VS; Cowman AF; Mohmmed A; Malhotra P
    Mol Biochem Parasitol; 2007 Nov; 156(1):12-23. PubMed ID: 17698213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.